Not Selling This Stock Before 10x Return - I Am Buying More

Link to Join on Patreon
In this video, I am discussing, why Cassava Sciences stock dropped to $79 from a high of 112 this week. And what is my stance on Cassava Sciences going forward…
In a recent analyst upgrade US financial services firm Cantor Fitzgerald downgraded the Cassava Sciences from overweight to neutral, but increased its price target to $100. On the other hand the Cantor Fitzgerald’s analyst Charles Duncan believes that the program insufficiently de-risked for Cassava shares to trade significantly higher than current levels, after having appreciated by over 1,400% year-to-date.
Now let’s see whether this downgrading is based upon facts and figures or the Cantor Fitzgerald downgraded SAVA stock following the recent overall stock run up?
The only way to analyze Cassava Sciences is by analyzing the Alzheimer’s disease market, the available therapies or drugs to cure the disease, and comparing these therapies with Cassava’s Simufilam.

DISCLAIMER: Note that I am not a financial adviser and you should do your own due diligence before making any decision. I just share my views. I do not recommend basing any investment decisions on my videos. My videos are only made for educational and entertainment purposes.

[Thetruth]

if the 9 and 12 month data is positive and savadx results are positive ( no company has ever done) this thing is going to explode. July 29 might be historic

[uk]

Fully agree markets are inefficient and price action controlled by institutions/hedge funds in the short term however with the great potential this stock has to treat this grave disease the stock price will soar….be patient….diamond hands….are important to consider

[aflahje]

I bought 20 shares at 82.5, then few days ago I was 450$ up but I didn't sold it, because I believe it has lot more potential, yesterday it went below and i bought more now I have 34 shares at average of 81.5, fingers crossed, let's hope for a green week.

[irex]

please give some information on BBKCF.

[IamMonikaDLC]

No I don't doubt it at all, all you have to do is look at the option chain charging an absolute crapton for super OTM calls to know this will x2 very soon

[spicytuna]

for those all going thru AD, we need a breakthrough.

[x.investor.education]

Euphoria!! Down 20% in a week. Sell off before another 20% down. This is not time for Euphoria stocks.

[jerrygutierrez]

Thank you I’m still holding to my Sava, thank you and God bless you 🙏

[michaelmoran]

Some great stocks out there. Unfortunately no one talks about macro events when pushing stocks.

[golammorshed]

Do you still stands for BIGG digital asset?

[PoidaPweter]

What's a good sale price then? Is it the $1, 000 mark?

[vt]

Please do an updated video on SAVA! When is a good time to take profit?!

[josecastillo]

You only like to talk about stocks that have been good predictions, but u don’t follow up on anything else, Rqhtf, Sbbp, scyx for example all bust and no updates

[David_USC]

Bought 250 shares after a week of thorough DD. I'll trade 50 shares short term, holding the rest for the buyout. There will be a bidding war for this company.

[gilbertgrejp]

What date (exaxtly) is the presentation? Is this on the discord? Thank you.

[Ark]

This is biotech and you must consider the high risk, so I guess you cant say this is middle or safe investment ?

[andres]

I thought the fda had board members who quit because the drug didn’t work and it was passed any way? Is this the same company or a different one

[rachitjobalia]

Super overvalued, that data better be good or this will drop to under 200 million market cap before you blink your eye.

[renjithpk]

You've been pumping this for a while, is this a paid promotion? disclosure please.

[specialdispatch]

You shouldn't be talking about Biotech . The risk is really really high